Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1969 May;48(5):856–859. doi: 10.1172/JCI106043

Serum kynurenine in rheumatoid arthritis

Harry Spiera 1, Ramon Vallarino 1
PMCID: PMC322293  PMID: 5780196

Abstract

The concentration of kynurenine has been measured in the serum of patients with rheumatoid arthritis and in a control group. The mean serum concentration was 2.27 ± 0.688 μg/ml for patients with rheumatoid arthritis and 2.95 ± 0.825 μg/ml for the control group.

Kynurenine: creatinine clearance ratios were higher in the rheumatoid arthritis than in the control group. These data suggest that the increased urinary excretion of kynurenine by patients with rheumatoid arthritis is due at least in part to renal factors.

Full text

PDF
859

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman K., Greengard O. Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction. J Clin Invest. 1966 Oct;45(10):1527–1534. doi: 10.1172/JCI105459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BEETHAM W., Jr, FISCHER S., SCHROHENLOHER R. TRYPTOPHAN METABOLITE EXCRETION IN CONNECTIVE TISSUE DISEASES DEMONSTRATING A DIFFERENCE BETWEEN RHEUMATOID SPONDYLITIS AND RHEUMATOID ARTHRITIS. Proc Soc Exp Biol Med. 1964 Dec;117:756–759. doi: 10.3181/00379727-117-29689. [DOI] [PubMed] [Google Scholar]
  3. BETT I. M. Metabolism of tryptophan in rheumatoid arthritis. Ann Rheum Dis. 1962 Mar;21:63–69. doi: 10.1136/ard.21.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COPPINI D., BENASSI C. A., MONTORSI M. Quantitative determination of tryptophan metabolites (via kynurenine) in biologic fluids. Clin Chem. 1959 Oct;5:391–401. [PubMed] [Google Scholar]
  5. FLINN J. H., PRICE J. M., YESS N., BROWN R. R. EXCRETION OF TRYPTOPHAN METABOLITES BY PATIENTS WITH RHEUMATOID ARTHRITIS. Arthritis Rheum. 1964 Jun;7:201–210. doi: 10.1002/art.1780070303. [DOI] [PubMed] [Google Scholar]
  6. MUSAJO L., BENASSI C. A. ASPECTS OF DISORDERS OF THE KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN MAN. Adv Clin Chem. 1964;7:63–135. doi: 10.1016/s0065-2423(08)60373-x. [DOI] [PubMed] [Google Scholar]
  7. McMillan M. THE IDENTIFICATION OF A FLUORESCENT REDUCING SUBSTANCE IN THE URINE OF PATIENTS WITH RHEUMATOID ARTHRITIS: THE EXCRETION OF 3-HYDROXYANTHRANILIC ACID IN THIS AND OTHER CONDITIONS. J Clin Pathol. 1960 Mar;13(2):140–148. doi: 10.1136/jcp.13.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PINALS R. S. TRYPTOPHAN METABOLISM IN RHEUMATIC DISEASE. Arthritis Rheum. 1964 Dec;7:662–669. doi: 10.1002/art.1780070606. [DOI] [PubMed] [Google Scholar]
  9. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  10. SPIERA H., CHRISTIAN C. L. SOME FACTORS INFLUENCING URINARY EXCRETION OF 3-HYDROXYANTHRANILIC ACID. Proc Soc Exp Biol Med. 1964 Aug-Sep;116:944–947. doi: 10.3181/00379727-116-29415. [DOI] [PubMed] [Google Scholar]
  11. TOMPSETT S. L. The determination in urine of some metabolites of tryptophankynurenine, anthranilic acid and 3-hydroxyanthranilic acid- and reference to the presence of o-aminophenol in urine. Clin Chim Acta. 1959 May;4(3):411–419. doi: 10.1016/0009-8981(59)90112-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES